Literature DB >> 6865618

[The role of the cricopharyngeal muscle in phonation].

F Martin, F Klingholz.   

Abstract

Intraluminal esophageal manometry has been employed to study cricopharyngeal muscular function at different pitch levels. The activity of the cricopharyngeal muscle (CP) increases continually with rising pitch but is not influenced by the vocal sound pressure level. In the lower part of the chest register, the muscular pressure is lower than the pharyngo-esophageal pressure at rest. At high pitch levels, the pressure is higher than during swallowing. The CP has a dual function: With increasing pitch, the CP cooperates synergistically with the cricothyroid muscle (CT), indicated by increasing muscular pressure in the upper esophageal sphincter. On the other hand, the CP shortens the vocal cords by rotating the cricoid cartilage in anterior direction, thus acting antagonistically to the CT.

Entities:  

Mesh:

Year:  1983        PMID: 6865618

Source DB:  PubMed          Journal:  Laryngol Rhinol Otol (Stuttg)        ISSN: 0340-1588


  4 in total

1.  The functional anatomy of the cricothyroid joint.

Authors:  Gunther Windisch; Georg Philipp Hammer; Peter Michael Prodinger; Gerhard Friedrich; Friedrich Anderhuber
Journal:  Surg Radiol Anat       Date:  2009-10-08       Impact factor: 1.246

2.  Quantifying contributions of the cricopharyngeus to upper esophageal sphincter pressure changes by means of intramuscular electromyography and high-resolution manometry.

Authors:  Corinne A Jones; Michael J Hammer; Matthew R Hoffman; Timothy M McCulloch
Journal:  Ann Otol Rhinol Laryngol       Date:  2014-03       Impact factor: 1.547

Review 3.  The use of intraluminal manometry to assess upper esophageal sphincter function.

Authors:  B T Massey
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

4.  Innervation of the human cricopharyngeal muscle by the recurrent laryngeal nerve and external branch of the superior laryngeal nerve.

Authors:  Mehmet Uludag; Nurcihan Aygun; Adnan Isgor
Journal:  Langenbecks Arch Surg       Date:  2016-02-02       Impact factor: 3.445

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.